PXED vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

PXED

38.1
AI Score
VS
UTI Wins

UTI

39.4
AI Score

Investment Advisor Scores

PXED

38score
Recommendation
SELL

UTI

39score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric PXED UTI Winner
Forward P/E 5.8106 28.4091 PXED
PEG Ratio 0 1.8924 Tie
Revenue Growth 0.0% 7.2% UTI
Earnings Growth -28.9% -78.9% PXED
Tradestie Score 38.1/100 39.4/100 UTI
Profit Margin 8.2% 3.9% PXED
Beta 1.00 1.00 Tie
AI Recommendation SELL SELL Tie

Relative Price Performance (Last 90 Days)

PXED 1M: -0.4% · 3M: -14.1% UTI 1M: -20.8% · 3M: -50.2%

Current Technical Phase

PXED

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.8%), weak momentum, RSI 36

RSI (14): 36.3 · Price: $26.84

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.7%), weak momentum, RSI 27

RSI (14): 26.9 · Price: $20.31

Fundamentals Snapshot

Metric PXED UTI
Market Cap
Forward P/E 5.8 27.6
Trailing P/E 12.5 34.9
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.6% 0.6%
Operating Margin 0.2% 0.0%
EPS 2.15 0.59
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.